Table 5

Proportion with poor levels in metabolic control, by place of last outpatient visit.

Metabolic control indicators

Public hospital (%)

Public clinic (%)

Comm. health centers (%)

Private clinical setting (%)

Patient's home (%)

χ2 p-value


HbA1C ≥ 7%

36.5

33.6

38.4

43.0

28.9

-People with insulin (n = 154)

53.3

47.4

68.6

54.5

42.3

-People with oral medication (n = 346)

38.5

29.3

35.9

47.0

32.0

SBP ≥ 130 mmHga

82.7

74.8

78.3

80.2

68.5

-People with antihypertensive medication (n = 358)

81.1

73.2

84.3

75.3

72.0

DBP ≥ 80 mmHga

66.2

66.1

66.0

70.0

50.0

-People with antihypertensive medication (n = 358)

63.4

60.3

66.8

74.1

52.1

SBP ≥ 130 & DBP ≥ 80 mmHga

64.4

63.3

60.1

62.1

48.8

-People with antihypertensive medication (n = 358)

61.8

58.8

65.2

65.9

52.1

Triglycerides ≥ 150 mg/dl

42.5

39.9

56.6

33.6

63.6

***

-People with statin medication (n = 126)

49.6

40.3

71.3

32.0

73.6

**

LDL ≥ 100 mg/dl

72.7

79.9

84.0

66.8

70.1

-People with statin medication (n = 112)

77.7

79.8

84.3

47.7

84.4

HDL ≤ 40 mg/dl

68.9

75.6

70.1

62.4

62.9

Without aspirin intake

33.9

43.9

39.1

46.6

35.8

Without influenza vaccine last year

43.0

49.1

42.7

59.7

40.8

Without physician examination at least once a year

13.3

5.6

8.4

19.5

19.4

*


Notes: *: p < 0.10, **: p < 0.05, ***: p < 0.01

a/Arithmetic mean of two measurements

Brenes-Camacho and Rosero-Bixby BMC International Health and Human Rights 2008 8:5   doi:10.1186/1472-698X-8-5

Open Data